This evidence suggests a systemic impairment of platelet functionality and specifically of glutamate transport in ALS, as does the finding that platelets from ALS patients show a 37% increase in expression of glutamine synthetase [303], although in this study normal expression of the glutamate transporter EAAT2 was observed. This evidence concerns the gene GLUL and amyotrophic lateral sclerosis.